Summary
- Current Price
- As of today, IMDX price is $4.65, down -1.06% in the most recent trading session on
- Current Price All-Time High
- IMDX price is currently -97.73% below its historical high of $204.80 set on
- Market Cap
- IMDX current market cap is $150M, up +88.06% over the past 365 days
- Revenue
- IMDX current annual revenue is $4.06M, up +115.58% year-over-year
- Next Earnings
- The next earnings release for IMDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Insight Molecular Diagnostics Inc. |
| Ticker | NASDAQ: IMDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | imdxinc.com |
| Employees | 46 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.65 | ||
| Price, 1D Change | -1.06% | |
| $150M | ||
| - | ||
| - | ||
| 2.48 | ||
| $4M | ||
| Revenue, 1Y Change | +115.58% | |
| -$1.65 | ||
| EPS, 1Y Change | +64.65% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | OCX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.65 | ||
| EPS Estimate | N/A | -$0.85 |
| EPS Est. Change | N/A | +48.42% |
| $4.06M | ||
| Revenue Estimate | N/A | $2.15M |
| Revenue Est. Change | N/A | -47.05% |
| $4.65 | ||
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +93.55% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$4.66 | - | |
| -$1.15 | -$1.65 | -43.30% | |
| -$0.85 | N/A | +48.42% | |
| -$0.78 | N/A | +52.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.88M | - | |
| $3.23M | $4.06M | +25.74% | |
| $2.15M | N/A | -47.05% | |
| $7.72M | N/A | +90.50% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +66.67% | ||
| +8.64% | ||
| +88.06% | ||
| +8,414.95% | ||
| +115.58% | ||
| +323.28% | ||
| +64.65% | ||
| +87.57% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $4.65 | ||
| $5.46 | ||
| $5.53 | ||
| $4.97 | ||
| $5.16 | ||
| -$0.17 | ||
| 2.48 | ||
| $0.45 | ||
| 41.93 | ||
| 76.81% | ||
| 106.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $4.06M | ||
| -$1.65 | ||
| $190.00K | ||
| 4.69% | ||
| -$30.58M | ||
| -754.08% | ||
| -$50.22M | ||
| -1,238.52% | ||
| -$28.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.11 | ||
| 1.27 | ||
| 1.23 | ||
| - | ||
| 2 | ||
| -23.82 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 77.04 | ||
| -14.04 | ||
| -3.81 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$31.46M | ||
| $12.31M | ||
| $25.76M | ||
| $15.31M | ||
| $57.22M | ||
| $12.08M | ||
| $3.50M | ||
| $1.81M | ||
| $2.54M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $54.28M | ||
| $30.77M | ||
| $3.87M | ||
| $0.00 | ||
| $2.20M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$22.18M | ||
| -$3.19M | ||
| $28.07M | ||
| $3.19M | ||
| -$25.37M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Lake Street | → | |
| Needham | → | |
| Needham | → | |
| Lake Street | → | |
| Needham | → | |
| Needham | → | |
| Lake Street | ||
| Stephens & Co. | → | |
| Stephens & Co. | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with IMDX
FAQ
What is the ticker symbol for Insight Molecular Diagnostics Inc.?
The ticker symbol for Insight Molecular Diagnostics Inc. is NASDAQ:IMDX
Does Insight Molecular Diagnostics Inc. pay dividends?
No, Insight Molecular Diagnostics Inc. does not pay dividends
What sector is Insight Molecular Diagnostics Inc. in?
Insight Molecular Diagnostics Inc. is in the Healthcare sector
What industry is Insight Molecular Diagnostics Inc. in?
Insight Molecular Diagnostics Inc. is in the Diagnostics & Research industry
What country is Insight Molecular Diagnostics Inc. based in?
Insight Molecular Diagnostics Inc. is headquartered in United States
When did Insight Molecular Diagnostics Inc. go public?
Insight Molecular Diagnostics Inc. initial public offering (IPO) was on December 30, 2015
Is Insight Molecular Diagnostics Inc. in the S&P 500?
No, Insight Molecular Diagnostics Inc. is not included in the S&P 500 index
Is Insight Molecular Diagnostics Inc. in the NASDAQ 100?
No, Insight Molecular Diagnostics Inc. is not included in the NASDAQ 100 index
Is Insight Molecular Diagnostics Inc. in the Dow Jones?
No, Insight Molecular Diagnostics Inc. is not included in the Dow Jones index
When was Insight Molecular Diagnostics Inc. last earnings report?
Insight Molecular Diagnostics Inc.'s most recent earnings report was on May 13, 2026
When does Insight Molecular Diagnostics Inc. report earnings?
The next expected earnings date for Insight Molecular Diagnostics Inc. is August 10, 2026
Data Sources & References
- IMDX Official Website imdxinc.com
- IMDX Profile on Yahoo Finance finance.yahoo.com/quote/IMDX
- IMDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imdx